Chief Business & Strat Officer
Mon, Aug 12, 2024
Aug 12
exercised or converted securities in APLS
5,201 shares @ $13.85
Increased holdings by +9.40%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology